Human immunoglobulin (pH4, Sinopharm Shanghai Plasma-Derived Biotherapies)
静注人免疫球蛋白(pH4，上海血液制品研究所)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameHuman immunoglobulin (pH4, Sinopharm Shanghai Plasma-Derived Biotherapies)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved Indications +[6]
Approved Indications in China +[6]
Original Approved Country/Territory
Original Approved Date1999/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSinopharm Shanghai Plasma-Derived Biotherapies Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShanghai Institute of Biological Products Co Ltd
Inactive CompaniesN/A
Active Indications +[6]
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A